Skip to main content

VGM & ASSOCIATESHealthcare MSO

Search GO

Search GO

VGM & ASSOCIATESHealthcare MSO LEARN ABOUT VGM

Durable Medical Equipment Community Emergency Response Committee Established. Please Complete Survey!

Published in Government Relations on October 21, 2021

DME Community Emergency Response Earlier this year, southern states like Texas and Oklahoma were hit with an unexpected winter storm that left many, including patients reliant on oxygen and other powered DME, without power for days. That’s when HME state associations, VGM, and industry leaders stepped in to begin establishing processes are needed to assist beneficiaries in their time of need. Emergency Preparedness for Home Medical Equipment Suppliers Committee was established to address these issues. The goal of the newly established group is to bring awareness to federal and state emergency management groups of the need for breathing and mobility devices during a natural disaster. The committee also aims to put together a roadmap or toolkit for DME suppliers to follow in these emergency situations.

Emergency Preparedness Committee Members Include:

Dawn Seek - MNCHA
Larry Dalton - OMEPA
Beth Bowen - ACMESA/ATHOMES/NEMEP/FAHCS
Bob Achermann - CAMPS
Rose Schafhauser - MAMES/SWMESA
Victoria Peterson - TexMEP
Mike Calcaterra - Big Sky AMES/PAMES
Chris Townsend- FAHCS
John Gallagher and Emily Harken of VGM

The group has already met with Tangita Daramola, the Competitive Acquisition Ombudsman for CMS, as well as other CMS officials in an effort to connect with larger audiences at the federal level, bringing awareness of DMEPOS communities’ importance and needs during an emergency.

In order for effective changes to be made, we need to hear from you! Please take a minute to answer the 10 question survey below regarding your experiences during a disaster. The information will be collected and sent to appropriate officials who may be able to assist in improved processes and programs.

The survey closes on November 11.

TAGS

From Our Experts

Proposed Rule Suggests Significant Change To Accreditation Process thumbnail

Proposed Rule Suggests Significant Change To Accreditation Process The recently released proposed rule CMS-1828-P contains a significant change that could reshape how suppliers navigate accreditation. The rule proposes a major change that would require suppliers to be surveyed and reaccredited annually instead of the current three (3) year cadence. This proposal raises substantial questions about both operational feasibility and cost implications.

August Of Action: Your Chance To Connect With Congress thumbnail

August Of Action: Your Chance To Connect With Congress It's time to take advantage of August Of Action—a perfect opportunity to make your voice heard. Every summer, federal legislators return to their home states during the Congressional recess. While it gives them a break from Washington D.C., it's primarily a time for them to connect with constituents like you.

HR1 Passes House, Advances to President Trump's Desk for Signature thumbnail

HR1 Passes House, Advances to President Trump's Desk for Signature After extensive negotiations and partisan debate, the House has officially passed HR1, clearing the path for the bill to be signed into law by President Donald Trump. The legislation, which aims to reduce federal healthcare expenditures, contains several provisions that may impact the durable medical equipment, prosthetics, orthotics, and supplies (DMEPOS) industry.

CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program thumbnail

CMS files the Proposed Rule that sheds light on the next round of the Competitive Bidding Program On June 30, 2025, CMS filed the anticipated Proposed Rule that includes updates to the Competitive Bidding Program (CBP). Public comments are due 60 days from June 30, 2025. Below is a high-level summary of the rule. It is critical to note that, according to the Proposed Rule Fact Sheet dated June 30, 2025, CMS has stated that they have not announced the specific product categories they are bidding or the specific timeframe for the next competition. Those specifics will be forthcoming in a fu

Senate Narrowly Passes HR1, Sending It Back to House for Final Approval thumbnail

Senate Narrowly Passes HR1, Sending It Back to House for Final Approval President Donald Trump's sweeping legislative package, formally titled the One Big, Beautiful Bill Act, now referred to as HR1., cleared the Senate today in a dramatic 51–50 vote, with Vice President JD Vance casting the tie-breaking vote. The bill now returns to the House, where lawmakers must decide whether to adopt the Senate's revised version or negotiate further changes before it can reach the president's desk.

Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule thumbnail

Several Prominent Medicaid Provisions in Senate's Budget Bill Deemed in Violation of Byrd Rule Senate Parliamentarian Elizabeth MacDonough advised this week that multiple Medicaid provisions in the Senate's reconciliation bill would violate Senate procedure by violating the Byrd Rule. The Byrd Rule is a Senate-specific procedural process that allows Senators to prevent or block inclusion of extraneous provisions in reconciliation bills. Other provisions are still under review.

Evaluating the Value of a Payer Contract thumbnail

Evaluating the Value of a Payer Contract In our last article, Key Payers Denied Your Application Citing Their Network Is Closed – Now What?, we discussed strategies for addressing payer contracting denials due to a closed network. As indicated, this process can be an extremely time-consuming exercise with no guarantees and mixed results. Below are a few things to consider as you evaluate whether a contract is worth the extra effort.

Webinar: "Navigating The New CMS Landscape: RADs, HMVs, and Supplier Survival" on June 25 at 1 p.m. CT. The Centers for Medicare & Medicaid Services (CMS) has released its final National Coverage Determination (NCD) for RADs and HMVs used in treating chronic respiratory failure due to COPD. While the rule potentially expands access to bilevel ST therapy (RADs), it also introduces complex compliance requirements, tighter usage criteria, and increased documentation burdens—without additional reimbursement.

Give your business an advantage over the competition.

Become a Member